U.S. markets closed

COMPASS Pathways plc (CMPS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
41.08+1.47 (+3.71%)
At close: 4:00PM EST
Sign in to post a message.
  • L
    Love
    Back in at $41. GLTA!
  • S
    Steven
    Just got put on to this company today. Will be buying some this week.
  • C
    ConcernedCitizen
    I'm not a shareholder here as of yet. YET, but I do plan on loading up in the coming month. I recently latched onto the CMPS story because another company I follow religiously has entered the microdosing psychedelic space as well. What's even more so in common is both companies share your Chair of Scientific Advisory Board, Prof David Nutt DM FRCP FRCPSYCH FSB FMEDSCI. A couple of days ago, I had the pleasure of listening to Dr. Nutt speak alongside Algernon Pharmaceuticals CEO at the Psychedelic Capital Virtual Investment Conference. He's a brilliant speaker/thinker. I'm expecting BIG BIG things for both companies in the near term future.

    Due Diligence read: https://finance.yahoo.com/news/algernon-pharmaceuticals-ceo-speak-psychedelic-120000143.html

    Good Luck 2 All @ CMPS

    BH
  • J
    Jeffrey san
    looks like it retested support at 49 and held. Will head even higher soon :)
  • M
    Michael
    CMPS may be expensive compared to the other Psych companies, but is far ahead. COMP360 will be approved faster than extracts. Legal microdosing has so many more applications than just depression... listen to Tim Ferriss, etc.
    Bullish
  • Y
    Yahoo Finance Insights
    CMPS is up 11.88% to 50.48
  • J
    Jeffrey san
    Breakout confirmed! Good volume today, on our way to hit 60 first :)
  • F
    Franky
    proud holder of 42 shares. nice to finally be in.
  • J
    Jules
    Welp something lit a fire under Compass these last couple day. Holding long, and good to see the love.
  • w
    wise words
    will be up additional 20% after hours
  • S
    Stuart
    CMPS is the bellwether for the whole sector as its FDA fast tracked. look for more institutional investment to confirm trend. given the low float and Nasdaq listing it's the best and safest play far more then MMED with it's horrible share structure. I also invest in PSYK and TRIP which is building awareness and a brand as well as a path to revenue.
  • A
    Anthony
    This one is going to $200
  • E
    Elias
    noice
    Bullish
  • W
    Warrior Monk
    One of the best trades I ever made was buying into a company known as Tweed a little known MJ company at the time, that later became Canopy Growth. I am now focused on getting into psychedelic companies before the rush is on. The further ahead a company moves in the approval process, the more valuable the company becomes, Compass Pathways (CMPS) is in Phase 2b trials and has received a "Breakthrough Therapy" designation from the FDA, meaning that their therapy has the potential to be more effective than available medications. It's important in this kind of investment to be mindful of the stage a company is in. The only companies that have Phase 2 clinical trials now are Compass Pathways, Mind Medicine (MMEDF) , Cybin Inc. (CLXPF) , and Mydecine Innovations Group (MYCOF). I am currently holding positions in CMPS, MMEDF, CLXPF, LKYSF and TRUFF. As always, do your own research and make up your own mind. I use a category minded approach on an investment like this. I also tend to invest in steps and try to grab deals on dips as well as dump investments that underperform over time.
  • i
    inittowinit
    This company has legs! Stick with it.
    Bullish
  • C
    Cnote
    10 yrs ...this will be the treatment for most mental health disorders.
  • D
    Derek
    why up so much today?
  • S
    Saba
    This is peanuts for what is to come
    Bullish
  • B
    Bryan
    message for retail: it looks like someone is trying to push us out and make money doing at the same time. If I were you, I would hold. PT 200 (2-3 year hold). ST: 80-100 (6 months - 1 year, if your into that). I would post this on a rainy day but then I'd be a bag holder.
  • E
    Emran
    This is wonderful stock, could touch $100, strong buy rating.